Twist Bioscience Corp Stock Price To Earning

TWST Stock

USD 48.32 1.98 4.27%

Twist Bioscience Corp fundamentals help investors to digest information that contributes to Twist Bioscience's financial success or failures. It also enables traders to predict the movement of Twist Stock. The fundamental analysis module provides a way to measure Twist Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Twist Bioscience stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Twist Bioscience Corp Company Price To Earning Analysis

Twist Bioscience's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Twist Price To Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for Twist Bioscience is extremely important. It helps to project a fair market value of Twist Stock properly, considering its historical fundamentals such as Price To Earning. Since Twist Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Twist Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Twist Bioscience's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Invested Capital	Net Working Capital	Deferred Long Term Liab	Common Stock
Total Assets		0.98	0.9	0.16	-0.87	-0.84	0.75	-0.89	0.97	0.8	0.41	-0.76	0.9	-0.18	-0.21	0.98	0.72	0.88	0.79	0.89	0.97	-0.25	0.89
Total Stockholder Equity	0.98		0.9	0.23	-0.84	-0.82	0.73	-0.9	0.96	0.76	0.5	-0.86	0.89	-0.36	-0.23	0.97	0.71	0.84	0.75	0.9	0.96	-0.23	0.85
Net Tangible Assets	0.9	0.9		0.0	-0.72	-0.98	0.44	-0.91	0.92	0.93	0.42	-0.84	1.0	-0.33	-0.26	0.86	0.9	0.74	0.93	0.87	0.85	-0.61	0.96
Current Deferred Revenue	0.16	0.23	0.0		-0.42	0.07	0.37	-0.33	0.15	-0.33	0.22	-0.29	0.01	-0.39	0.18	0.34	0.07	-0.16	-0.35	-0.09	0.36	0.29	-0.08
Net Debt	-0.87	-0.84	-0.72	-0.42		0.65	-0.77	0.75	-0.77	-0.58	-0.11	0.59	-0.73	0.07	0.21	-0.92	-0.59	-0.71	-0.54	-0.56	-0.92	0.16	-0.73
Retained Earnings	-0.84	-0.82	-0.98	0.07	0.65		-0.36	0.89	-0.89	-0.95	-0.33	0.73	-0.98	0.2	0.2	-0.79	-0.92	-0.69	-0.95	-0.83	-0.77	0.67	-0.96
Accounts Payable	0.75	0.73	0.44	0.37	-0.77	-0.36		-0.57	0.66	0.33	0.26	-0.43	0.45	-0.02	-0.08	0.77	0.15	0.77	0.31	0.59	0.75	0.29	0.39
Long Term Debt	-0.89	-0.9	-0.91	-0.33	0.75	0.89	-0.57		-0.94	-0.74	-0.57	0.82	-0.92	0.35	0.11	-0.91	-0.84	-0.64	-0.74	-0.83	-0.9	0.44	-0.84
Net Receivables	0.97	0.96	0.92	0.15	-0.77	-0.89	0.66	-0.94		0.81	0.5	-0.79	0.92	-0.25	-0.17	0.94	0.77	0.82	0.81	0.93	0.92	-0.3	0.89
Good Will	0.8	0.76	0.93	-0.33	-0.58	-0.95	0.33	-0.74	0.81		0.22	-0.63	0.93	-0.07	-0.26	0.7	0.83	0.76	1.0	0.82	0.69	-0.68	0.94
Short Term Investments	0.41	0.5	0.42	0.22	-0.11	-0.33	0.26	-0.57	0.5	0.22		-0.61	0.4	-0.56	0.09	0.46	0.35	0.26	0.26	0.64	0.46	-0.09	0.3
Long Term Debt Total	-0.76	-0.86	-0.84	-0.29	0.59	0.73	-0.43	0.82	-0.79	-0.63	-0.61		-0.81	0.77	0.27	-0.77	-0.68	-0.55	-0.63	-0.78	-0.77	0.36	-0.7
Capital Surpluse	0.9	0.89	1.0	0.01	-0.73	-0.98	0.45	-0.92	0.92	0.93	0.4	-0.81		-0.28	-0.23	0.86	0.91	0.73	0.93	0.86	0.86	-0.62	0.96
Total Liab	-0.18	-0.36	-0.33	-0.39	0.07	0.2	-0.02	0.35	-0.25	-0.07	-0.56	0.77	-0.28		0.18	-0.24	-0.23	0.02	-0.08	-0.3	-0.26	0.13	-0.12
Short Long Term Debt	-0.21	-0.23	-0.26	0.18	0.21	0.2	-0.08	0.11	-0.17	-0.26	0.09	0.27	-0.23	0.18		-0.18	-0.03	-0.22	-0.25	-0.15	-0.19	0.17	-0.26
Total Current Assets	0.98	0.97	0.86	0.34	-0.92	-0.79	0.77	-0.91	0.94	0.7	0.46	-0.77	0.86	-0.24	-0.18		0.71	0.8	0.68	0.82	1.0	-0.22	0.84
Short Term Debt	0.72	0.71	0.9	0.07	-0.59	-0.92	0.15	-0.84	0.77	0.83	0.35	-0.68	0.91	-0.23	-0.03	0.71		0.45	0.82	0.66	0.71	-0.77	0.91
Intangible Assets	0.88	0.84	0.74	-0.16	-0.71	-0.69	0.77	-0.64	0.82	0.76	0.26	-0.55	0.73	0.02	-0.22	0.8	0.45		0.75	0.84	0.78	-0.11	0.74
Property Plant Equipment	0.79	0.75	0.93	-0.35	-0.54	-0.95	0.31	-0.74	0.81	1.0	0.26	-0.63	0.93	-0.08	-0.25	0.68	0.82	0.75		0.83	0.67	-0.69	0.93
Net Invested Capital	0.89	0.9	0.87	-0.09	-0.56	-0.83	0.59	-0.83	0.93	0.82	0.64	-0.78	0.86	-0.3	-0.15	0.82	0.66	0.84	0.83		0.8	-0.29	0.8
Net Working Capital	0.97	0.96	0.85	0.36	-0.92	-0.77	0.75	-0.9	0.92	0.69	0.46	-0.77	0.86	-0.26	-0.19	1.0	0.71	0.78	0.67	0.8		-0.24	0.84
Deferred Long Term Liab	-0.25	-0.23	-0.61	0.29	0.16	0.67	0.29	0.44	-0.3	-0.68	-0.09	0.36	-0.62	0.13	0.17	-0.22	-0.77	-0.11	-0.69	-0.29	-0.24		-0.62
Common Stock	0.89	0.85	0.96	-0.08	-0.73	-0.96	0.39	-0.84	0.89	0.94	0.3	-0.7	0.96	-0.12	-0.26	0.84	0.91	0.74	0.93	0.8	0.84	-0.62

Click cells to compare fundamentals

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Competition

Predict Twist Bioscience

Twist Retained Earnings

Retained Earnings

(1.18 Billion)

At this time, Twist Bioscience's Retained Earnings are comparatively stable compared to the past year.

Based on the latest financial disclosure, Twist Bioscience Corp has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.0% higher than that of the company.

Twist Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Twist Bioscience's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Twist Bioscience could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics of similar companies.

Twist Bioscience is currently under evaluation in price to earning category among its peers.

Twist Bioscience ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Twist Bioscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Twist Bioscience's managers, analysts, and investors.

Environmental

Governance

Social

Twist Fundamentals

	Return On Equity	-0.38
	Return On Asset	-0.16
	Profit Margin	(0.75) %
	Operating Margin	(0.54) %
	Current Valuation	2.68 B
	Shares Outstanding	59.36 M
	Shares Owned By Insiders	1.94 %
	Shares Owned By Institutions	98.06 %
	Number Of Shares Shorted	8.75 M
	Price To Book	6.07 X
	Price To Sales	9.72 X
	Revenue	312.97 M
	Gross Profit	84.23 M
	EBITDA	(176.71 M)
	Net Income	(208.73 M)
	Cash And Equivalents	504.97 M
	Cash Per Share	8.93 X
	Total Debt	85.03 M
	Debt To Equity	0.12 %
	Current Ratio	6.58 X
	Book Value Per Share	8.39 X
	Cash Flow From Operations	(64.09 M)
	Short Ratio	15.97 X
	Earnings Per Share	(3.60) X
	Price To Earnings To Growth	(0.04) X
	Target Price	50.49
	Number Of Employees	919
	Beta	1.78
	Market Capitalization	2.87 B
	Total Asset	614.32 M
	Retained Earnings	(1.24 B)
	Working Capital	275.77 M
	Net Asset	614.32 M

About Twist Bioscience Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Twist Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC